Interim analysis: Open-label extension study of leniolisib for patients with APDS
Rao, V Koneti, Kulm, Elaine, Šedivá, Anna, Plebani, Alessandro, Schuetz, Catharina, Shcherbina, Anna, Dalm, Virgil A, Trizzino, Antonino, Zharankova, Yulia, Webster, Sharon, Orpia, Alanvin, Körholz, Julia, Lougaris, Vassilios, Rodina, Yulia, Radford, Kath, Bradt, Jason, Relan, Anurag, Holland, Steven M, Lenardo, Michael J, Uzel, Gulbu
Published in Journal of allergy and clinical immunology (01.01.2024)
Published in Journal of allergy and clinical immunology (01.01.2024)
Get full text
Journal Article
A Phase I Dose-Escalation Trial of BN-CV301, a Recombinant Poxviral Vaccine Targeting MUC1 and CEA with Costimulatory Molecules
Gatti-Mays, Margaret E, Strauss, Julius, Donahue, Renee N, Palena, Claudia, Del Rivero, Jaydira, Redman, Jason M, Madan, Ravi A, Marté, Jennifer L, Cordes, Lisa M, Lamping, Elizabeth, Orpia, Alanvin, Burmeister, Andrea, Wagner, Eva, Pico Navarro, Cesar, Heery, Christopher R, Schlom, Jeffrey, Gulley, James L
Published in Clinical cancer research (15.08.2019)
Published in Clinical cancer research (15.08.2019)
Get full text
Journal Article
Interim Analysis of Safety and Hematological Parameters of an Ongoing Long-Term Open-Label Extension Study of Investigational PI3Kδ Inhibitor Leniolisib for Patients with Activated PI3K Delta Syndrome (APDS) through December 2021
Rao, V. Koneti, Webster, Sharon, Sediva, Anna, Plebani, Alessandro, Schuetz, Catharina, Shcherbina, Anna, Dalm, Virgil A.S.H., Trizzino, Antonino, Zharankova, Yulia, Kulm, Elaine, Orpia, Alanvin, Chirombo Kluczynski, Lavenda, Körholz, Julia, Lougaris, Vassilios, Rodina, Yulia, Kucher, Klaus, Radford, Kath, Bradt, Jason, Uzel, Gulbu
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)‐Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer
Gatti‐Mays, Margaret E., Redman, Jason M., Donahue, Renee N., Palena, Claudia, Madan, Ravi A., Karzai, Fatima, Bilusic, Marijo, Sater, Houssein Abdul, Marté, Jennifer L., Cordes, Lisa M., McMahon, Sheri, Steinberg, Seth M., Orpia, Alanvin, Burmeister, Andrea, Schlom, Jeffrey, Gulley, James L., Strauss, Julius
Published in The oncologist (Dayton, Ohio) (01.06.2020)
Published in The oncologist (Dayton, Ohio) (01.06.2020)
Get full text
Journal Article
A trial of CV301 in combination with anti-PD-1 therapy versus anti-PD-1 therapy in subjects with non-small cell lung cancer
Rajan, Arun, Strauss, Julius, Orpia, Alanvin, Gatti-Mays, Margaret Elena, Wagner, Eva, Heery, Christopher Ryan, Pico, Cesar, Gulley, James L.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
A Phase 1 Dose-Escalation Trial of BN-CV301, a Recombinant Poxviral Vaccine Targeting MUC-1 and CEA with Costimulatory Molecules
Gatti-Mays, Margaret E., Strauss, Julius, Donahue, Renee N., Palena, Claudia, Rivero, Jaydira Del, Redman, Jason, Madan, Ravi A., Marté, Jennifer N., Cordes, Lisa, Lamping, Elizabeth, Orpia, Alanvin, Burmeister, Andrea, Wagner, Eva, Navarro, Cesar Pico, Heery, Christopher R., Schlom, Jeffrey, Gulley, James L.
Published in Clinical cancer research (20.05.2019)
Published in Clinical cancer research (20.05.2019)
Get full text
Journal Article